Dr. Zachary Martin Gertz, MD

Dr. Gertz practices at VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia.

Dr. Gertz's NPI, 1457414849, was assigned on December 18, 2006. Dr. Gertz graduated from Perelman School of Med at the University of Pennsylvania in 2005. Dr. Gertz holds Virginia license 0101251784.

Dr. Gertz's primary practice is VCU Medical Center, at 1250 East Marshall Street, Richmond, VA 23298 in Richmond City. The practice phone is (804) 828-9000.

Dr. Gertz's primary practice is VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia. Dr. Gertz is also affiliated with Bon Secours Memorial Regional Medical Center. The medical group on file is MCV Physicians. Dmand AI also links Dr. Gertz to 3 more hospitals, 1 group practice or clinic and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gertz practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Gertz's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Gertz is licensed in Virginia.

CMS data shows 479 Medicare services from Dr. Gertz across 13 procedure codes in 2024, for 360 Medicare patients. Medicare paid $60,735 for them.

CMS counts 360 Medicare patients who saw Dr. Gertz in 2024. The largest group is 65 to 74, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gertz's median patient age at 72, with 46% women.

In 2024, Dr. Gertz wrote 173 Medicare Part D claims for 46 patients. 77% of them were for generic drugs. CMS names the drug for 83 of them, across 5 drugs with 11 or more claims each, at $21,129 in total drug cost. In 2023, CMS named 40 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Gertz for performance year 2024, reported as part of a group. Dr. Gertz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 67 papers to Dr. Gertz, published from 2010 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Cardiac Catheterization, Heart Failure and Aortic Valve Stenosis. Dr. Gertz has published most often in Catheter Cardiovasc Interv. Dr. Gertz's most frequent co-authors are Mohammed A. Quader, MD, Neil J. Weissman, MD and Howard C. Herrmann, MD.

Dmand AI links Dr. Gertz to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Heart Valve Diseases, Heart Failure and Mitral Valve Insufficiency.

CMS Open Payments shows 88 general payments to Dr. Gertz from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Edwards Lifesciences Corporation paid the most, $4,297.

Dr. Gertz graduated from Perelman School of Med at the University of Pennsylvania in 2005.